UCSF's Pilot Award for Prevention and Treatment of Opioid Use Disorders funds innovative translational and clinical research to advance prevention and treatment strategies for opioid misuse and addiction.
Funder: University of California San Francisco
Due Dates (Anticipated): March 2027 (Full application deadline, Spring cycle)
Funding Amounts: Up to $40,000 per project for one year; non-renewable.
Summary: Supports pilot research on innovative prevention and treatment strategies for opioid use disorders, emphasizing translational and clinical approaches.
Key Information: Only UCSF-affiliated faculty, postdocs, and fellows are eligible; residents and specialists are not eligible.
The Pilot Award for Prevention and Treatment of Opioid Use Disorders, offered by the University of California San Francisco (UCSF), is designed to support innovative pilot research addressing the opioid crisis. The program funds projects that generate preliminary data needed for future clinical trials or community interventions, with a focus on pain management, opioid prescribing patterns, and strategies for preventing or treating opioid misuse and addiction. Emphasis is placed on studies exploring the intersection of pain and addiction, implementation of evidence-based approaches in diverse settings, and research involving at-risk populations such as adolescents, young adults, individuals with Neonatal Abstinence Syndrome, homeless populations, and those with co-occurring health conditions.
The award encourages a broad range of translational and clinical research, including feasibility studies, secondary data analysis, development of new methodologies, and early-stage technology or therapy development. All funded projects must address at least one criterion of translational science as defined by the Clinical & Translational Science Institute (CTSI) at UCSF.